- Home
- VABK vs CMPX Comparison
VABK vs CMPX Comparison
Compare VABK & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VABK
- CMPX
- Stock Information
- Founded
- VABK 1998
- CMPX 2014
- Country
- VABK United States
- CMPX United States
- Employees
- VABK N/A
- CMPX N/A
- Industry
- VABK Major Banks
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- VABK Finance
- CMPX Health Care
- Exchange
- VABK Nasdaq
- CMPX Nasdaq
- Market Cap
- VABK 206.0M
- CMPX 214.6M
- IPO Year
- VABK N/A
- CMPX N/A
- Fundamental
- Price
- VABK $35.54
- CMPX $2.60
- Analyst Decision
- VABK
- CMPX Strong Buy
- Analyst Count
- VABK 0
- CMPX 4
- Target Price
- VABK N/A
- CMPX $13.75
- AVG Volume (30 Days)
- VABK 7.2K
- CMPX 2.2M
- Earning Date
- VABK 01-28-2025
- CMPX 11-12-2024
- Dividend Yield
- VABK 3.71%
- CMPX N/A
- EPS Growth
- VABK N/A
- CMPX N/A
- EPS
- VABK 2.89
- CMPX N/A
- Revenue
- VABK $51,571,000.00
- CMPX $850,000.00
- Revenue This Year
- VABK N/A
- CMPX N/A
- Revenue Next Year
- VABK N/A
- CMPX $613.39
- P/E Ratio
- VABK $12.30
- CMPX N/A
- Revenue Growth
- VABK N/A
- CMPX N/A
- 52 Week Low
- VABK $24.06
- CMPX $0.77
- 52 Week High
- VABK $44.00
- CMPX $2.70
- Technical
- Relative Strength Index (RSI)
- VABK 39.58
- CMPX 76.97
- Support Level
- VABK $34.65
- CMPX $1.43
- Resistance Level
- VABK $36.98
- CMPX $2.70
- Average True Range (ATR)
- VABK 1.27
- CMPX 0.29
- MACD
- VABK 0.01
- CMPX 0.12
- Stochastic Oscillator
- VABK 30.52
- CMPX 92.31
About VABK Virginia National Bankshares Corporation
Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses and charitable organizations.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.